BDH Industries Limited share price
BSE: BDH
Key numbers
- Market cap
- ₹ 282 Cr
- Current price
- ₹ 490.00
- 52-week high / low
- ₹ 610 / 340
- Stock P/E
- 24.1
- Book value
- ₹ 133.8
- Dividend yield
- 1.02%
- ROCE
- 20.5%
- ROE
- 14.8%
- Debt to equity
- 0.03
- Sales growth (3 yrs)
- 8.5%
- Profit growth (3 yrs)
- 9.6%
- 1-year return
- 13.1%
About BDH Industries Limited
BDH Industries Limited engages in the manufacture and sale of therapeutic formulations for pharmaceuticals in India and Internationally. The company operates in two segments, Pharmaceuticals and Renewable Energy. It offers finished pharmaceuticals products, such as analgesic antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, antiulcers, and antivirals. The company also provides sedative, anxiolytic, antidepressants, calcium suppliments, cardiovascular, carminative, aromatic, corticosteroids, diuretics, electrolyte replinishers, expectorant, iron supplimentry, laxatives, local anesthetic, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, skin protective, skin smoothner, vitamins, pharmaceutical aid, and drugs acting on uterus products. In addition, it offers alkay-er tablets; morphine sulphate…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 19 | 19 | 29 | 29 | 22 |
| Operating profit | 2 | 3 | 4 | 4 | 3 |
| Net profit | 2 | 3 | 3 | 3 | 3 |
| EPS (₹) | 3.17 | 4.55 | 6.06 | 5.00 | 4.73 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.